The chemical class of AKAP 149_AKAP 121 (AKAP1) activators encompasses a variety of compounds that, while not directly binding and activating AKAP1, have the potential to influence its activity by modulating associated signaling pathways, particularly those involving Protein Kinase A (PKA). These activators play a crucial role in modulating the scaffolding function of AKAP1, which is essential for the specific localization of PKA within the cell and thus has a significant impact on various cellular processes.
Compounds such as Cyclic AMP (cAMP), Forskolin, and Isoproterenol function by increasing cAMP levels within the cell. Elevated cAMP levels lead to the activation of PKA, which interacts with AKAP1 for targeted localization at specific cellular sites. This interaction is crucial for the precise regulation of PKA-mediated phosphorylation events. Similarly, IBMX and Rolipram, by inhibiting phosphodiesterases, lead to increased cAMP levels, thereby potentially enhancing the AKAP1-PKA interaction and its subsequent cellular functions. Adrenergic agonists like Epinephrine and adenosine receptor modulators like Adenosine also play a role in modulating cAMP levels, indirectly influencing AKAP1's role in PKA localization. Other members of this class, such as Caffeine and Theophylline, function similarly by increasing cAMP through phosphodiesterase inhibition. Additionally, compounds like Brevetoxin and Ouabain, while not directly interacting with the AKAP1-PKA axis, can indirectly influence cellular signaling pathways that may affect AKAP1's scaffolding function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $114.00 $175.00 $260.00 $362.00 $617.00 $1127.00 | ||
Increases PKA activity by binding to its regulatory subunits, which can enhance the scaffolding function of AKAP1 in localizing PKA to specific sites. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels and thereby enhancing PKA activity and its interaction with AKAP1. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
A β-adrenergic agonist that increases cAMP levels, potentially enhancing AKAP1-mediated localization of PKA. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, increases intracellular cAMP levels, indirectly enhancing AKAP1's role in PKA localization. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Selectively inhibits phosphodiesterase 4, leading to increased cAMP levels and potentially enhanced AKAP1-PKA interactions. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Stimulates adenylate cyclase via adrenergic receptors, increasing cAMP and thereby influencing AKAP1-mediated PKA targeting. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $33.00 $47.00 $294.00 $561.00 $1020.00 $2550.00 $4590.00 | 1 | |
Modulates cAMP levels through adenosine receptors, indirectly affecting AKAP1's role in PKA localization. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Inhibits phosphodiesterases, elevating cAMP levels and potentially enhancing the function of AKAP1 in PKA localization. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $31.00 $83.00 | 6 | |
Similar to caffeine, increases cAMP by inhibiting phosphodiesterases, potentially influencing AKAP1's scaffolding function. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $506.00 | |||
Inhibits the Na+/K+-ATPase, indirectly affecting intracellular signaling and potentially influencing AKAP1-PKA interactions. | ||||||